...Welcome to the Rush Enterprises, Inc. first-quarter #### earnings conference call. This call is being recorded. At this time for opening remarks and introductions, I would like to turn the call over to Mr. Marvin Rush, Chairman of the Board. Please go ahead, sir....

... - Morgan Stanley - AnalystPerfect. Thank you. Let's go ahead and get started. In case you don't know me my name is David Lewis. I'm a member of the medical device team here. Medical technology team here at Morgan Stanley. It's a pleasure to have with us here heading into the luncheon session the management team here from Affymetrix. We have both the CFO, John Batty, as well as the VP of Investor Relations, Doug Farrell. So for those of you who do not know Affymetrix, I want to give a quick spiel, ## seconds or so, on Affymetrix and what we think is interesting about the Company. For most of you who know Affymetrix has been a pretty significant participant in the Life Sciences tools continuum here for many, many years, with obviously their principal GeneChip technology. For a very long period of time that technology was mostly used for the R&A side of the world, the [RM], MRNA expression side of the world and now we have seen with more recent products that Affy is starting to compete...

...Good day, everyone, and welcome to the Buenaventura conference call. (OPERATOR INSTRUCTIONS) At this time, I'll turn the call over to Pete Majeski of i-advize for opening remarks and introductions. Please go ahead. ...

...Good day, ladies and gentlemen. Welcome to the Polypore International first quarter #### earnings results conference call. Today's conference is being recorded. At this time I would like to turn things over to Ms. [Kathy Broadbent]. Please go ahead, ma'am....

...Good afternoon, and welcome to Dollarama Group Holdings, LP, and Dollarama Group LP's conference call for the fourth quarter and fiscal year ended February #, ####. Today's call will be led by Mr. Larry Rossy, Chief Executive Officer; Mr. Stephane Gonthier, Chief Operating Officer; and Mr. Robert Coallier, Chief Financial Officer. They will begin with a short presentation followed by a question-and-answer period open exclusively to investors and financial analysts. I would now like to turn the conference over to Mr. Coallier. Please go ahead. ...

... - Morgan Stanley - Analyst-- of interested parties out there. So for those of you who don't know me, I'm David Lewis, a member of the medical device team here for Morgan Stanley. It's a pleasure to have with us this morning the management team from Hologic, or members of the management team. We have Glenn Muir, the Chief Financial Officer, as well as Pat Sullivan, EVP and Chairman. So Glenn, who is standing at the podium, he's going to come join us here in a second. Maybe he's afraid of me right now, I don't know. He'll give a brief overview of the business. Obviously today, I think given yesterday's results, we'll spend a lot of time today talking about where we are specifically on two issues. One of which obviously is NovaSur,e which luckily we have Pat here today. The other I think is going to be Selenia to a lesser extent, but I'm sure we can branch out from there. Obviously we'd love it to be an interactive session. Maybe that won't be a challenge here today. But with that I'll...

...Good day everyone and welcome to Airvana's first quarter fiscal #### financial results conference call. As reminder, today's call is being recorded. There will be an opportunity for questions after the prepared remarks. At this time, for opening remarks and introductions I would like to turn the call over to Airvana's Chief Financial Officer, Mr. Jeff Glidden. Please go ahead, sir. ...

...Good day, ladies and gentlemen, and welcome to the first quarter #### Genpact Limited earnings conference call. At this time, all participants are in a listen-only mode. We will be facilitating a question-and-answer session towards the end of this conference. (OPERATOR INSTRUCTIONS). As a reminder this conference is being recorded for replay purposes. I would now like to turn the presentation over to your host for today's call, Mr. Roanak Desai, head of Investor Relations and Corporate Development. Please proceed. ...

...I would now like turn the call over to Julie Davis, Director of Investor Relations. Please proceed, ma'am. ...

...Good day, ladies and gentlemen, and welcome to the first quarter #### Arbor Realty Trust Earnings Conference Call. My name is Marisol and I will be your conference coordinator for today. At this time, all participants are in listen-only mode. We will conduct a question and answer session towards the end of the conference. (OPERATOR DIRECTIONS) As a reminded, this conference is being recorded. I would now like to turn the presentation over to Mr. Paul Elenio, Chief Financial Officer. Please proceed, sir. Okay. Thank you, Marisol, and good morning, everyone, and welcome to the quarterly earnings call for Arbor Realty Trust. This morning we will discuss the results for the quarter ended March ##, ####. With me on the call today is Ivan Kaufman, our President and Chief Executive Officer. Before we begin, I need to inform you that statements made in this earnings call may be deemed forward-looking statements and subject to risks and uncertainties including information about possible or assumed...

...Good day, and welcome to the TRX first quarter earnings conference call. Please be aware that today's conference is being recorded. At this time, I'd like to turn the conference over to David Cathcart. Please go ahead, sir. ...

...Good day, everyone, and welcome to today's Agrium Incorporated conference call. Following today's remarks, we will conduct an electronic question-and-answer session. Instructions on how to pose your questions will be given that time. As a reminder, this call is being recorded. Now, for opening remarks and introductions, I would like to turn the conference over to Mr. Richard Downey, Senior Director of Investor Relations. Please go ahead, sir. ...

... - Morgan Stanley - Analyst, Moderator I think we're going to go ahead and get started here. Good morning, everybody. My name is David Roman. Joining me today from Stryker is Steve MacMillan, President and Chief Executive Officer, and Katherine Owen, Director of Investor Relations. I hope I didn't botch the titles too much. Why don't we jump right into the reconstructive markets? We now have the benefit of every company having reported earnings, including Smith & Nephew, this morning. Maybe you can just give us some reflections on the overall health of the market, both hips and knees, and where you think we're going for the second quarter and then maybe your broader outlook on the market. ...

...Great, well, let's go ahead and get started. It's my pleasure to have with me today two members of the management team from Gen-Probe Corporation, both the CFO, Herm Rosenman, and the VP-Investor Relations, Mike Watts -- maybe Senior VP, Mike. Don't come after me! (LAUGHTER) Anyway, Gen-Probe Corporation -- what I'd like to do is talk very briefly about the Company and what I think is most interesting from defining the investment debate, or at least try to. Herm has told me that he would like a more interactive session now. He's blaming me for not having more interactive sessions, so he's going to hold my feet to the fire if you don't ask questions, so I made kind of call people out in a very Socratic method, so beware. So, real quickly on Gen-Probe, for those of you who do not know, Gen-Probe today -- a leader in molecular diagnostics broadly. They really have two independent segments. One I define as clinical diagnostics; the other I define as sort of blood screening. The Company is a...

...Okay. So, we're happy to have Isolagen here. Thanks for attending and with me I have Todd Greenspan, CFO, Declan Daly, CEO, and Nick Teti, Chairman. So, thanks for joining us, and I was just wondering if you could start with a ten-minute overview of your company for those who are not familiar? ...

...Good day, ladies and gentlemen, and welcome to the first quarter #### American Public Education, Inc. earnings conference call. My name is Akia, and I will be your operator for today. At this time, all participants are in a listen-only mode. We will conduct a question and answer session towards the end of the call. (OPERATOR INSTRUCTIONS) I would now like to turn the presentation over to your host for today's call, Mr. Chris Symanoskie. Please proceed, sir. ...

...Hello, and welcome to the Validus Holdings, Ltd. First Quarter #### Conference Call. (OPERATOR INSTRUCTIONS). Please note this conference is being recorded. Now I would like to turn the conference over to Mr. Jon Levenson. Mr. Levenson, you may begin. ...

... - Morgan Stanley - AnalystFor those of you that know me, I'm David Veal, the healthcare services analyst here at Morgan Stanley. To my right is my colleagues Andrew Olsen who works on my team, Dr. Paul Berger, the Founder and CEO of NightHawk Radiology, and Andrea Clegg, the Vice President of Investor Relations. Dr. Berger, would you like to kick us off with the few comments? ...

... - Morgan Stanley - AnalystWelcome, and good morning, everybody. Thanks for making it out on a Friday morning. We're going to start out this morning with Genentech. We have Ken Hillan. Ken runs the Immunology and Tissue Repair division inside of Genentech. And if we have -- I think if people have any other broader questions, Kathee Littrell is in the audience with a microphone, so she can answer some of those. For those on the webcast, if you read our disclosures for Morgan Stanley, go to www.morganstanley.com; and for those of you here, you know they're out in the hall. I'm sure Genentech has some disclosures on the website. We're going to make you make forward-looking statements; you're going to have to. Why don't you start out? Because you are in the business that had some very recent setbacks. And I think it's been an area that a lot of people have had a lot of questions. And it's looking at Rituxan in some of the new opportunities. So, if you want to give us just a little bit of...

...Ladies and gentlemen, thank you for standby. Welcome to the Q# #### TimberWest Forest Corporation analyst conference call. (Operator Instructions). As a reminder, this conference is being recorded this Thursday, May #, ####. A rebroadcast of today's conference will be available beginning today at # PM Eastern Standard Time through May ## #:## AM Eastern Standard Time. To access the rebroadcast, you may dial ###-###-#### or ###-###-#### and enter reservation number ########. I would now like to turn the conference call over to Paul McElligott, President and CEO of TimberWest Forest Corporation. Please proceed with your presentation. ...

...Good day, ladies and gentlemen, and welcome to the first quarter #### Affinion Group, Inc., earnings conference call. (OPERATOR INSTRUCTIONS) I would now turn the call over to Mr. James Hart, Senior Vice President of Investor Relations. Mr. Hart, please proceed. ...

...Please be advised this conference call is being recorded. Good afternoon, good morning, and welcome to the NorthBridge first quarter results conference call and webcast for Friday, May #, ####. Your host for today will be Mr. Mark Ram. Mr. Ram, please go ahead. ...

...Good morning. My name is Heather, and I will be your conference operator today. At this time, I would like to welcome everyone to the Tesco Corporation First Quarter #### earnings release conference call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. (OPERATOR INSTRUCTIONS). Thank you. Mr. Quintana, you may begin your conference. ...

...Good morning, ladies and gentlemen, and thank you for participating in the Mid-America Apartment Communities first quarter earnings release conference call. The Company will first share its prepared comments, followed by a question-and-answer session. At this time, we would like to turn the call over to Leslie Wolfgang, Director of External Reporting. Ms. Wolfgang, you may begin. ...

...Good day, everyone. Welcome to the Merrill Lynch Cardinal Health Pharma distribution call. Today's call is being recorded. For opening remarks and introductions I'd like to turn the call over to Mr. Tom Gallucci. Please go ahead, sir. ...

...Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to the Morguard REIT #### first quarter results conference call. At this time, all participants are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session. Instructions will be provided at that time for you to queue up for questions. (OPERATOR INSTRUCTIONS). I would like to remind everyone that this conference call is being recorded on Friday, May #nd, #### at # eastern time. I will now turn the conference over to Mr. Tim Walker, Chief Financial Officer. Please go ahead. ...

...Please be advised that this conference call is being recorded. Good afternoon, and welcome to the IGM Financial first quarter earnings results conference call for Friday, May #nd, ####. Your hosts for today will be Charlie Sims and Murray Taylor. Please go ahead, Mr. Sims. ...

...Continues to take advantage of what seems to be a disconnect between share price and net asset value buying back #.#m shares so far in #### while maintaining comfortable liquidity. ...

...Over the years, common and preferred share issuance has led some to comment Co. has grown absolutely but not on a per share basis. ...

...Book value per share increased by ##.#% to $###.## per share, not including $# per share per share dividend paid in #Q##. ...

...As suggested in #Q## call, although not immune to slower GDP growth or recessions, Co. believes that it is well positioned to perform in most economic environments. ...

... - RLI Corp. - ChairmanThank you, Jon, and good afternoon, everyone. ## years have gone by in a flash. Let's see. There were many challenges, as many of you know, that have been with us for a long time, along the way. And it's always been interesting how we grew and where ...

... - Morgan Stanley - AnalystThanks, everybody. Next we have Amgen. We have Bob Bradway, the CFO, and Arvind Sood, who is the Director of Investor Relations. For those of you who are listening on the webcast, you can go to www.MorganStanley.com for our disclosures. For those of you here, they are out in the hallway as we talked about before, I'm sure you have yours on the website as well because we are optimistic you will make some forward-looking statements. I will start with a general question to begin with. It has been a very difficult operational year for Amgen. With the safety issues that you have dealt with on the erythropoietin business, the necessity to change the size of your business, just give a little bit of an overview of where you are in restructuring this business to one, find areas where you can drive topline growth, and two, getting the right operational infrastructure in place to ensure that you can protect your bottom line while still looking for long-term growth as well?...

...Good day ladies and gentlemen and welcome to the first-quarter #### Barnes Group earnings conference call. My name is Dan and I will be your coordinator for today. At this time all participants in listen-only mode. We will be facilitating a question-and-answer session toward the end of this conference. (OPERATOR INSTRUCTIONS). As a reminder this conference is being recorded for replay purposes. I'd now like to turn the call over to your host for today's call, Mr. Brian Koppy. Please proceed sir....

... - Morgan Stanley - AnalystThanks, everybody, for joining us. Next up we have Colin Goddard and OSI Pharmaceuticals. Colin, thanks for coming down to Florida....

... - Morgan Stanley - AnalystFor those of you on the webcast, this is Glenn Reicin from Morgan Stanley. With me today is Dominic Caruso, CFO of Johnson & Johnson, and Louise Mehrotra, who is VP of Investor Relations at J&J as well. I've been told that her title is VP of IR, but she's the Queen of IR according to Dominic here. So -- I guess you didn't think I was going to say that. But I figured we'd keep it light here.Why don't we open it up a little bit with Dominic starting off and maybe give us a report card on how you're doing this year. Look at the first quarter, tell us -- obviously we never get a chance to really see your business plan, maybe you can tell us what is on plan, what's above plan, below plan and we can use that as a basis to start off our conversation here. ...

...Good day and welcome to iStar Financial's first quarter #### earnings conference call. (OPERATOR INSTRUCTIONS). As a reminder today's conference is being recorded. At this time for of the remarks and introductions I would like to turn the conference over to iStar Financial's Senior Vice President of Investor Relations and Marketing, Mr. Andrew Backman. Please go ahead, Sir. ...

...Good afternoon, ladies and gentlemen, and welcome to Techwell's first quarter #### financial results conference call for the period ended March ##,####. (OPERATOR INSTRUCTIONS) I will now turn the call over to [Beverly Tween] of Shelton Group Investor Relations. Beverly, please go ahead. ...

...Good afternoon, ladies and gentlemen. Welcome to the Q# #### earnings call for Investools. At this time, all participants are in a listen-only mode. Following the presentation, we will conduct a question and answer session. (OPERATOR INSTRUCTIONS) As a reminded, this call is being recorded. I will now turn the conference over to Mr. Paul Helbling. Please go ahead, sir. ...

...Good day, and welcome to the TranS#, Inc. first quarter #### conference call. Today's conference is being recorded. At this time I'd like to turn the conference over to Mr. Mark Klausner, of Westwicke Partners